← Back to DFTX

Definium Therapeutics, Inc. - Common Shares financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 07/05/2026Sep 2025Filed 06/11/2025Jun 2025Filed 06/08/2026Mar 2025Filed 07/05/2026Sep 2024Filed 06/11/2025Jun 2024Filed 31/07/2025Mar 2024Filed 08/05/2025
−$159−$77−$67−$43−$23−$14−$5.9−$54
−$1.44−$0.71−$0.78−$0.50−$0.35−$0.27−$0.26−$1.14
111109868587807548

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.